Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07640685 · ClinicalTrials.gov registry record · NA
UCLA Magnesium Formulation Athlete Study
A NA study, sponsored by University of California, Los Angeles.
- Not yet
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT07640685 is a NA study that has not yet begun recruiting, run by University of California, Los Angeles. The registered enrollment target is 150 participants.
The verdict
NCT07640685, a NA study, has not yet begun recruiting, sponsored by University of California, Los Angeles.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
This randomized, double-blind, placebo-controlled trial will compare magnesium glycinate, magnesium L-threonate, and placebo in UCLA varsity athletes. Participants will complete a baseline monitoring period followed by 4 weeks of blinded nightly supplementation. WHOOP or study-approved wearable data will be used to evaluate sleep efficiency, total sleep time, sleep consistency, heart rate variability, resting heart rate, and recovery metrics. Baseline and final testing will assess selected reaction and physical performance outcomes. The primary outcome is change in WHOOP-derived sleep efficiency from baseline week to final treatment week.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Magnesium glycinate
- DIETARY_SUPPLEMENT Magnesium L-threonate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-07 |
| Est. Completion | 2027-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07640685
The ClinicalTrials.gov registry entry for NCT07640685 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT07640685 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07640685 about?
NCT07640685 is a clinical study titled "UCLA Magnesium Formulation Athlete Study". This randomized, double-blind, placebo-controlled trial will compare magnesium glycinate, magnesium L-threonate, and placebo in UCLA varsity athletes. Participants will complete a baseline monitoring period followed by 4 weeks of blinded nightly supplementation. WHOOP or study-approved wearable data...
What is the current status of trial NCT07640685?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2026-07. Estimated completion is 2027-06.
What interventions are being tested in trial NCT07640685?
The interventions under investigation include: Placebo (OTHER), Magnesium glycinate (DIETARY_SUPPLEMENT), Magnesium L-threonate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07640685?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.